The original success of the copyright undeniably revolutionized the medication landscape, but investing in companies primarily reliant on generic versions presents a complex picture. Despite early earnings were impressive, the expiration of patents and the emergence of cheaper alternatives have eroded the customer base. Therefore, a thorough eva… Read More